Latest Nycomed Stories
MELVILLE, N.Y., Aug. 1, 2011 /PRNewswire/ -- Nycomed US Inc. ("Nycomed US") today announced the appointment of Brian A.
LAUSANNE, Switzerland, July 11, 2011 /PRNewswire/ -- EffRx Pharmaceuticals SA, an Epalinges/Lausanne, Switzerland based drug delivery company, announces that US patent 7,964,212 was issued on June 21, 2011, enhancing the protection of EX101. This patent grants significant additional Intellectual Property concerning the EffRx Lead Program, EX101 (70 mg effervescent alendronate for the treatment of osteoporosis). The extended range of intellectual property in this...
FLORHAM PARK, N.J., July 11, 2011 /PRNewswire/ -- PharmaDerm, a division of Nycomed US Inc., announced today the availability of prescription drug assistance programs to reduce health insurance co-payments for six primary dermatological brands.
EAST RUTHERFORD, N.J.
OSAKA, Japan, and ZURICH, May 19, 2011 /PRNewswire/ -- Takeda Pharmaceutical Company Limited ("Takeda", TSE: 4502) and Nycomed A/S ("Nycomed") jointly announced today that Takeda has reached an agreement with the shareholders of Nycomed in which Takeda will acquire the Zurich-headquartered company for 9.6 billion Euro on a cash-free, debt-free basis.
MELVILLE, N.Y., May 19, 2011 /PRNewswire/ -- Nycomed US Inc., a wholly owned subsidiary of Nycomed, announced today that it will become an independent corporation and will no longer be affiliated with Nycomed following the acquisition of its parent company by Takeda Pharmaceutical Company Ltd.
ALLEGAN, Mich., May 10, 2011 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced that it has agreed to settle all Hatch-Waxman litigation relating to fluticasone lotion brought by Nycomed US Inc. by taking a license under all relevant patents.
CUPERTINO, Calif., May 5, 2011 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) announced today financial results for the three months ended March 31, 2011.
- An imitative word; an onomatopoetic word.